company background image
RGC logo

Regencell Bioscience Holdings NasdaqCM:RGC Stock Report

Last Price

US$7.23

Market Cap

US$94.0m

7D

-11.5%

1Y

-51.4%

Updated

30 Aug, 2024

Data

Company Financials

Regencell Bioscience Holdings Limited

NasdaqCM:RGC Stock Report

Market Cap: US$94.0m

RGC Stock Overview

Operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong.

RGC fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Regencell Bioscience Holdings Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Regencell Bioscience Holdings
Historical stock prices
Current Share PriceUS$7.23
52 Week HighUS$32.44
52 Week LowUS$3.03
Beta-0.49
11 Month Change-24.92%
3 Month Change53.83%
1 Year Change-51.44%
33 Year Change-75.75%
5 Year Changen/a
Change since IPO-31.14%

Recent News & Updates

Here's Why We're Not Too Worried About Regencell Bioscience Holdings' (NASDAQ:RGC) Cash Burn Situation

Nov 18
Here's Why We're Not Too Worried About Regencell Bioscience Holdings' (NASDAQ:RGC) Cash Burn Situation

Recent updates

Here's Why We're Not Too Worried About Regencell Bioscience Holdings' (NASDAQ:RGC) Cash Burn Situation

Nov 18
Here's Why We're Not Too Worried About Regencell Bioscience Holdings' (NASDAQ:RGC) Cash Burn Situation

Slow And Steady Wins The Race With Regencell Bioscience

Aug 16

Shareholder Returns

RGCUS PharmaceuticalsUS Market
7D-11.5%1.1%0.06%
1Y-51.4%20.0%22.6%

Return vs Industry: RGC underperformed the US Pharmaceuticals industry which returned 19.3% over the past year.

Return vs Market: RGC underperformed the US Market which returned 22.2% over the past year.

Price Volatility

Is RGC's price volatile compared to industry and market?
RGC volatility
RGC Average Weekly Movement110.2%
Pharmaceuticals Industry Average Movement10.1%
Market Average Movement6.3%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market3.1%

Stable Share Price: RGC's share price has been volatile over the past 3 months.

Volatility Over Time: RGC's weekly volatility has increased from 61% to 110% over the past year.

About the Company

FoundedEmployeesCEOWebsite
201412Yat-Gai Auwww.regencellbioscience.com

Regencell Bioscience Holdings Limited operates as a Traditional Chinese medicine (TCM) bioscience company in Hong Kong. It focuses on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degeneration, primarily for attention deficit hyperactivity disorder and autism spectrum disorder, as well as infectious diseases. The company was incorporated in 2014 and is headquartered in Causeway Bay, Hong Kong.

Regencell Bioscience Holdings Limited Fundamentals Summary

How do Regencell Bioscience Holdings's earnings and revenue compare to its market cap?
RGC fundamental statistics
Market capUS$93.95m
Earnings (TTM)-US$4.71m
Revenue (TTM)n/a

0.0x

P/S Ratio

-20.0x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
RGC income statement (TTM)
RevenueUS$0
Cost of RevenueUS$0
Gross ProfitUS$0
Other ExpensesUS$4.71m
Earnings-US$4.71m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.36
Gross Margin0.00%
Net Profit Margin0.00%
Debt/Equity Ratio0%

How did RGC perform over the long term?

See historical performance and comparison